NO146137C - Fremgangsmaate ved fremstilling av farvestabiliserte, terapeutisk aktive salicylatforbindelser - Google Patents

Fremgangsmaate ved fremstilling av farvestabiliserte, terapeutisk aktive salicylatforbindelser

Info

Publication number
NO146137C
NO146137C NO2651/72A NO265172A NO146137C NO 146137 C NO146137 C NO 146137C NO 2651/72 A NO2651/72 A NO 2651/72A NO 265172 A NO265172 A NO 265172A NO 146137 C NO146137 C NO 146137C
Authority
NO
Norway
Prior art keywords
color
procedure
preparation
therapeutic active
salicylate compounds
Prior art date
Application number
NO2651/72A
Other languages
English (en)
Other versions
NO146137B (no
Inventor
William Kelly
Alfred Halpern
Original Assignee
Mundipharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mundipharma Ag filed Critical Mundipharma Ag
Publication of NO146137B publication Critical patent/NO146137B/no
Publication of NO146137C publication Critical patent/NO146137C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO2651/72A 1971-07-26 1972-07-25 Fremgangsmaate ved fremstilling av farvestabiliserte, terapeutisk aktive salicylatforbindelser NO146137C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3494171A GB1397732A (en) 1971-07-26 1971-07-26 Stabilized choline salicylate compounds

Publications (2)

Publication Number Publication Date
NO146137B NO146137B (no) 1982-04-26
NO146137C true NO146137C (no) 1982-08-04

Family

ID=10371855

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2651/72A NO146137C (no) 1971-07-26 1972-07-25 Fremgangsmaate ved fremstilling av farvestabiliserte, terapeutisk aktive salicylatforbindelser

Country Status (13)

Country Link
US (1) US3855282A (no)
AU (1) AU461584B2 (no)
CA (1) CA1009664A (no)
CH (1) CH590816A5 (no)
DE (1) DE2222902C2 (no)
DK (1) DK145540C (no)
ES (2) ES402541A1 (no)
FR (1) FR2147170B1 (no)
GB (1) GB1397732A (no)
IL (1) IL40542A (no)
IN (1) IN139346B (no)
NO (1) NO146137C (no)
ZA (1) ZA722798B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4098813A (en) * 1971-07-24 1978-07-04 Mundipharma Ag Preparation of alkali metal choline salicylate salt complexes
EP0051962B1 (en) * 1980-11-05 1988-08-24 Sumitomo Chemical Company, Limited Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
US5043168A (en) * 1990-04-26 1991-08-27 Sidmak Laboratories, Inc. Solid choline magnesium salicylate composition and method of preparing same
DE10227793A1 (de) * 2002-06-21 2004-01-08 Basf Ag Stabilisierte Cholinascorbat enthaltende Zusammensetzung
WO2006005692A1 (en) * 2004-07-09 2006-01-19 Akzo Nobel N.V. Composition comprising choline hydroxide and process for preparing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1000902A (fr) * 1949-11-29 1952-02-18 Chimiotherapie Lab Franc Procédé amélioré pour la préparation des solutions aqueuses de sels d'acide paraaminosalicylique
DE1104118B (de) * 1959-05-15 1961-04-06 Benckiser Gmbh Joh A Verfahren zur Erhoehung der thermischen Stabilitaet von waessrigen, pharmakologisch wirksamen Aminozuckerderivatloesungen
US3069321A (en) * 1960-04-04 1962-12-18 Lab For Pharmaceutical Dev Inc Choline salicylate composition and methods of use
US3549370A (en) * 1966-11-23 1970-12-22 Hunt Chem Corp Philip A Quaternary ammonium bisulfites,sulfites or pyrosulfites as developer preservatives
DE1956626A1 (de) * 1969-11-11 1971-05-19 Basf Ag Verfahren zur Herstellung von Sulfitobetainen

Also Published As

Publication number Publication date
IL40542A0 (en) 1972-12-29
ES402541A1 (es) 1975-04-01
ZA722798B (en) 1973-01-31
DK145540B (da) 1982-12-06
AU461584B2 (en) 1975-05-29
NO146137B (no) 1982-04-26
IL40542A (en) 1979-07-25
DE2222902C2 (de) 1985-06-13
DK145540C (da) 1983-05-02
FR2147170A1 (no) 1973-03-09
AU4232372A (en) 1973-11-22
US3855282A (en) 1974-12-17
ES410123A1 (es) 1976-05-16
DE2222902A1 (de) 1973-02-08
FR2147170B1 (no) 1976-04-16
GB1397732A (en) 1975-06-18
CH590816A5 (no) 1977-08-31
IN139346B (no) 1976-06-12
CA1009664A (en) 1977-05-03

Similar Documents

Publication Publication Date Title
NO143909C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive penicillinforbindelser
NO138805C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive triazolforbindelser
SE385891B (sv) Forfarande for framstellning av bensopyranforeningar
NO145883C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7-methoxy-7-acylamino-cefalosporansyrederivater
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
NO136298C (no) Analogifremgangsm}te til fremstilling av antibakterielt virksomme imidazolderivater
NO138883C (no) Fremgangsmaate for fremstilling av oksiranforbindelser
NO147916C (no) Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser.
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
FI49827C (fi) Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-hydroksimetyy li-isokinoliinien valmistamiseksi.
NO146137C (no) Fremgangsmaate ved fremstilling av farvestabiliserte, terapeutisk aktive salicylatforbindelser
SE412756B (sv) Alternativa forfarande for framstellning av 2-(aminofenylimino)-3-aza-1-tia-cykloalkaner
SE7505279L (sv) Forfarande for framstellning av hydroxipyrimidiner.
SE406587B (sv) Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE411759B (sv) Forfarande for framstellning av erytromycyliminforeningar
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
NO136198C (no) Analogifremgangsm}te ved fremstilling av terapeutisk aktivt 16-carboxy-17-methoxy-eburnan.
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
NO138147C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 15alfa,16alfa-methylen-4-pregnener
SE399426B (sv) Forfarande for framstellning av dibens /c,e/ azepin-5-oner
NO143535C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oxazolopyridiner
SE392724B (sv) Forfarande for framstellning av 7-aminocefalosporansyra